Cumulative exposure to tacrolimus during early period after liver transplantation does not affect the recurrence of hepatocellular carcinoma

The clinical effects of tacrolimus (TAC) exposure on hepatocellular carcinoma (HCC) recurrence after liver transplantation (LT) remain unclear. In this retrospective single centric study, 512 patients who underwent LT for HCC were divided into four groups according to cumulative exposure to tacrolim...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Deok-Gie, Yim, Seung Hyuk, Min, Eun-Ki, Choi, Mun Chae, Joo, Dong Jin, Kim, Myoung Soo, Lee, Jae Geun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658176/
https://www.ncbi.nlm.nih.gov/pubmed/37981643
http://dx.doi.org/10.1038/s41598-023-46803-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658176/
https://www.ncbi.nlm.nih.gov/pubmed/37981643
http://dx.doi.org/10.1038/s41598-023-46803-8

Ejemplares similares